Mostafa Ronaghi - 11 Apr 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Bhaskar Anand, as Attorney-in-Fact for Mostafa Ronaghi
Issuer symbol
SMMT
Transactions as of
11 Apr 2024
Net transactions value
$0
Form type
4
Filing time
15 Apr 2024, 09:21:46 UTC
Previous filing
16 Jun 2023
Next filing
06 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +200,000 200,000 11 Apr 2024 Common Stock 200,000 $4.03 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award +25,315 +13% 225,315 11 Apr 2024 Common Stock 25,315 $4.03 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on April 11, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 11, 2025, subject to the director remaining as a non-salaried director on each such vesting date.
F2 Not applicable.
F3 The option was granted on April 11, 2024 and represents a pro rata amount of the annual 35,000 option board grant based approximately on the number of days the reporting person is anticipated to serve as a director in 2024. The shares underlying the option are scheduled to vest in full on December 31, 2024, subject to the director remaining as a non-salaried director on such vesting date.